Medicare billing address
CMS Medicare provider billing file
100 E Lancaster Ave Ste 230Wynnewood, PA 19096
CMS public data · NPI 1659434165
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Eliot B Friedman, MD
Specialty
Credential
MD
NPI
1659434165
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Eliot B Friedman, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
100 E Lancaster Ave Ste 230CMS Doctors & Clinicians file
255 W Lancaster AveIn the 2024 CMS provider billing file, this NPI had 842 Medicare beneficiaries and 1,799 total services. The average beneficiary age was 74, and the average HCC risk score was 1.8.
Total Medicare allowed amount
$231,976.74
Total Medicare payment amount
$181,165.67
Medicare beneficiaries
842
Total services
1,799
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
51%
CMS beneficiary-panel share
Diabetes
38%
CMS beneficiary-panel share
Chronic kidney disease
35%
CMS beneficiary-panel share
Heart failure
32%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 577 | $130.72 |
| Critical care, first 30-74 minutes | 307 | $213.20 |
| Test to measure expiratory airflow and volume | 159 | $28.12 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 152 | $184.78 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 116 | $119.61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 59 | $16.63 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 49 | $174.78 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 48 | $171.35 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 45 | $90.41 |
| Sleep study in sleep lab (6 years or older) | 37 | $117.63 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1659434165. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 84.6 | $1,986.73 |
| 2 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 66 | 98 | $61,456.09 |
| 3 | Trazodone Hcl | Trazodone Hcl | 59 | 107.1 | $364.13 |
| 4 | Clonazepam | Clonazepam | 58 | 76 | $462.23 |
| 5 | Prednisone | Prednisone | 43 | 43 | $120.62 |
| 6 | Breo Ellipta | Fluticasone/Vilanterol | 24 | 40 | $15,861.63 |
| 7 | Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 24 | 40 | $18,123.15 |
| 8 | Zolpidem Tartrate | Zolpidem Tartrate | 24 | 24 | $96.38 |
| 9 | Azithromycin | Azithromycin | 22 | 26 | $59.38 |
| 10 | Sunosi | Solriamfetol Hcl | 22 | 22 | $17,635.25 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1999
Group/practice field
Pulmonology Associates Inc
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Critical Care (Intensivists).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.